Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Alterity Therapeutics Limited (NASDAQ: ATHE)
ATHE Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-5.30%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
ATHE Stock Analysis
ATHE
PE Ratio:
ATHE
PEG Ratio:
Not Available
ATHE
Forward EPS Growth (12 month):
0.00%
ATHE
PS Ratio:
6.1
ATHE
PSG Ratio:
Not Available
ATHE
Forward Revenue Growth (12 month):
0.00%
ATHE Articles
No data was found